SERB and Stark International’s $800 Million Acquisition of BTG Specialty Pharmaceuticals

Shearman & Sterling represented Boston Scientific in the transaction. Eight Advisory represented Serb. Mayer Brown represented Serb and Charterhouse. Boston Scientific executed the pending sale of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here